Investor Overview

NASDAQ: XBIT0.038.51Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
DateTitle 
01/29/19Dr. Eric Simpson to Present Bermekimab Results in Atopic Dermatitis at 2019 AAD Annual MeetingPrinter Friendly Version
01/28/19Dr. Alice Gottlieb to Present Hidradenitis Suppurativa Findings at American Academy of Dermatology Annual MeetingPrinter Friendly Version
01/23/19Bermekimab Successfully Treats Hidradenitis Suppurativa, Including Significant Reduction in PainPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »